Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictors of left ventricular remodeling after ST-elevation myocardial infarction.
Hendriks T, Hartman MHT, Vlaar PJJ, Prakken NHJ, van der Ende YMY, Lexis CPH, van Veldhuisen DJ, van der Horst ICC, Lipsic E, Nijveldt R, van der Harst P. Hendriks T, et al. Among authors: lexis cph. Int J Cardiovasc Imaging. 2017 Sep;33(9):1415-1423. doi: 10.1007/s10554-017-1131-1. Epub 2017 Apr 7. Int J Cardiovasc Imaging. 2017. PMID: 28389968 Free PMC article.
Metformin in non-diabetic patients presenting with ST elevation myocardial infarction: rationale and design of the glycometabolic intervention as adjunct to primary percutaneous intervention in ST elevation myocardial infarction (GIPS)-III trial.
Lexis CP, van der Horst IC, Lipsic E, van der Harst P, van der Horst-Schrivers AN, Wolffenbuttel BH, de Boer RA, van Rossum AC, van Veldhuisen DJ, de Smet BJ; GIPS-III Investigators. Lexis CP, et al. Cardiovasc Drugs Ther. 2012 Oct;26(5):417-26. doi: 10.1007/s10557-012-6413-1. Cardiovasc Drugs Ther. 2012. PMID: 22968678 Free PMC article. Clinical Trial.
The feasibility of optical coherence tomography guided thrombus aspiration in patients with non-ST-elevation myocardial infarction after initial conservative therapy--a pilot study.
Wieringa WG, Lexis CP, Diercks GF, Lipsic E, Tan ES, Schurer RA, van der Werf HW, van den Heuvel AF, Suurmeijer AJ, Zijlstra F, de Smet BJ, Pundziute G. Wieringa WG, et al. Int J Cardiol. 2013 Oct 12;168(5):4981-2. doi: 10.1016/j.ijcard.2013.07.133. Epub 2013 Aug 3. Int J Cardiol. 2013. PMID: 23916781 No abstract available.
Metformin for cardiovascular disease: promise still unproven.
Lexis CP, van der Horst IC. Lexis CP, et al. Lancet Diabetes Endocrinol. 2014 Feb;2(2):94-5. doi: 10.1016/S2213-8587(13)70171-2. Epub 2013 Nov 7. Lancet Diabetes Endocrinol. 2014. PMID: 24622700 Free article. No abstract available.
Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial.
Lexis CP, van der Horst IC, Lipsic E, Wieringa WG, de Boer RA, van den Heuvel AF, van der Werf HW, Schurer RA, Pundziute G, Tan ES, Nieuwland W, Willemsen HM, Dorhout B, Molmans BH, van der Horst-Schrivers AN, Wolffenbuttel BH, ter Horst GJ, van Rossum AC, Tijssen JG, Hillege HL, de Smet BJ, van der Harst P, van Veldhuisen DJ; GIPS-III Investigators. Lexis CP, et al. JAMA. 2014 Apr 16;311(15):1526-35. doi: 10.1001/jama.2014.3315. JAMA. 2014. PMID: 24687169 Clinical Trial.
30 results